Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?

Parkinson's disease (PD) is a neurodegenerative disease affecting 7–10 million people worldwide. Currently, there is no treatment available to prevent or delay PD progression, partially due to the limited understanding of the pathological events which lead to the death of dopaminergic neurons i...

Descripción completa

Detalles Bibliográficos
Autores principales: Furgiuele, Alessia, Pereira, Frederico C, Martini, Stefano, Marino, Franca, Cosentino, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Special Feature Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540835/
https://www.ncbi.nlm.nih.gov/pubmed/37781343
http://dx.doi.org/10.1002/cti2.1469

Ejemplares similares

Ejemplares similares